New Information on Statins and Cardiovascular Risk – Asrar Qureshi’s Blog Post #1169
New Information on Statins and Cardiovascular Risk – Asrar Qureshi’s Blog Post #1169 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1169 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: Franki Frank Credit: Pavel Danilyuk Preamble This blog post is based on a recent article published in JAMA - Journal of American Medical Association. Link to article at the end. Rethinking Risk: How New Equations Could Alter Cardiovascular Prevention Cardiovascular disease remains a leading cause of death worldwide. Deciding who should receive preventive therapy, like statins, depends heavily on risk estimation models. For years, clinicians have relied on the Pooled Cohort Equations (PCEs), developed in 2013, to estimate a person’s 10-year risk of atherosclerotic cardiovascular disease (ASCVD). But medical science e...